Problem statement: Answer the multiple choice question.
Question: Which drug exhibits a 1.774% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
[a] Cc1ccc(C2/C(=C(/O)c3cnn(-c4ccccc4)c3C)C(=O)C(=O)N2CCN2CCOCC2)o1
[b] CCn1ncc(NC(=O)Nc2cccc(C(F)(F)F)c2)c1C(N)=O
Answer: b. CCn1ncc(NC(=O)Nc2cccc(C(F)(F)F)c2)c1C(N)=O
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCn1ncc(NC(=O)Nc2cccc(C(F)(F)F)c2)c1C(N)=O
CCn1ncc(NC(=O)Nc2cccc(C(F)(F)F)c2)c1C(N)=O
2-ethyl-4-[[3-(trifluoromethyl)phenyl]carbamoylamino]pyrazole-3-carboxamide